Background: The optimal approach to patients with suspected common bile duc
t (CBD) stones remains unsettled. Options include pre- and postoperative en
doscopic retrograde cholangiopancreatography (ERCP) or laparoscopic explora
tion of the CBD. This retrospective study evaluates the role of ERCP in the
management of suspected CBD stones, with an emphasis on indications, endos
copic findings, and outcome.
Methods: We retrospectively reviewed the consecutive medical records of 99
patients (67 females and 32 males) who underwent ERCP for suspected CBD sto
nes between March 1992 and December 1995.
Results: In 86 patients, ERCP was performed preoperatively, Indications for
ERCP included jaundice, pancreatitis, elevated liver functions tests (LFT)
, and ultrasound (US) or computed tomography (CT) scan findings. Forty one
(48%) of 86 preoperative ERCP had positive findings; 37 (43%) were negative
, and in 8 (9%) we failed to demonstrate the CBD. There were seven (8%) maj
or complications: four cases of acute pancreatitis, one case of acute bleed
ing, and two cases of acute bleeding with perforation. There was no mortali
ty. When pancreatitis was the only indication for ERCP, 0 of 8 patients had
positive findings in comparison with 50% when pancreatitis was associated
with jaundice and LFT, and 93% when US or CT scan demonstrated stones or di
lation of the CBD.
Conclusions: We conclude that ERCP is a valuable option for management of C
BD stones but should be performed selectively. Neither pancreatitis alone n
or LFT alone is an indication for ERCP. The presence of CBD stones is more
likely when multiple indications are present.